A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

NCT00426764 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
131
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene